Zi-lin Huang

Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Hepatic arterial infusion chemotherapy with anti-angiogenesis agents and immune checkpoint inhibitors for unresectable hepatocellular carcinoma and meta-analysis.

Hepatic arterial infusion chemotherapy with anti-angiogenesis agents and immune checkpoint inhibitors for unresectable hepatocellular carcinoma and meta-analysis.

Journal: World journal of gastroenterology

Published: November 01, 2023

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study.

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study.

Journal: Signal transduction and targeted therapy

Published: July 04, 2023

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Journal: Medicine

Published: October 03, 2019

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.

Journal: Frontiers in oncology

Published: July 28, 2019

Alternative splicing events are prognostic in hepatocellular carcinoma.

Alternative splicing events are prognostic in hepatocellular carcinoma.

Journal: Aging

Published: April 24, 2019

Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.

Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.

Journal: World journal of gastrointestinal oncology

Published: March 27, 2019

Profiles of m6A RNA methylation regulators for the prognosis of hepatocellular carcinoma.

Profiles of m6A RNA methylation regulators for the prognosis of hepatocellular carcinoma.

Journal: Oncology letters

Published: January 20, 2019

Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.

Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.

Journal: Molecular and clinical oncology

Published: July 04, 2018

Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm.

Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm.

Journal: AJR. American journal of roentgenology

Published: December 25, 2014

Value of CIK in the treatment of TACE combined with RFA for HCC in long-term survival and prognostic analysis

Value of CIK in the treatment of TACE combined with RFA for HCC in long-term survival and prognostic analysis

Journal: Zhonghua yi xue za zhi

Published: January 19, 2013

Efficacy of minimally invasive therapies on unresectable pancreatic cancer.

Efficacy of minimally invasive therapies on unresectable pancreatic cancer.

Journal: Chinese journal of cancer

Published: September 11, 2012

Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging.

Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging.

Journal: European journal of radiology

Published: June 29, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026